Could a diabetes drug help people stop using cannabis?
NCT ID NCT07468552
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a medicine called tirzepatide to see if it can help people with moderate to severe cannabis use disorder use less cannabis or stop altogether. One hundred adults aged 18 to 70 will receive either the drug or a placebo, and researchers will track their cannabis use and any side effects. The goal is to find a safe dose that helps reduce cravings and use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genes may determine who gets hooked or psychotic from cannabis
- Could a natural brain chemical help tame cannabis cravings and lift mood?
- Brain scans reveal hidden links between depression, cannabis, and HIV in young adults
- Brain zaps could curb cannabis cravings in youth
- New pill aims to take the edge off quitting weed
- CBD vs. weed: can hemp help heavy users quit?